Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BBS5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KCMF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIML2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUS4L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC73 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPM1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLX4IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALG13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIR3DL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DOCK8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507353 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNMB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM4C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YTHDC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARFGEF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on